Aprea Therapeutics, Inc. (APRE)
Operating Cash Flow Growth
-4.73%
Quarterly · Period ending:
APRE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-4.73%period ending
Latest reported-4.73%period ending
APRE Quarterly Cash from Operations YoY % (-103.45% → -4.73%)
Year-over-year change
High-resolution chart · PNG
APRE operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -4.7276% | |
| 24.0815% | |
| 15.6544% | |
| -28.4782% | |
| 14.0286% | |
| 7.7423% | |
| 6.117% | |
| -10.0955% | |
| -13.2027% | |
| -32.1176% | |
| 6.9855% | |
| 65.9931% | |
| 63.8656% | |
| 45.7889% | |
| 60.5011% | |
| 19.9276% | |
| -14.8445% | |
| 52.3062% | |
| 22.8833% | |
| 37.4272% | |
| 19.5722% | |
| -52.7802% | |
| -26.5571% | |
| -105.18% | |
| -72.1098% | |
| -79.676% | |
| -170.8054% | |
| -103.4486% |